LPIC
CVS icon

LeJeune Puetz Investment Counsel’s CVS Health CVS Stock Holding History

LeJeune Puetz Investment Counsel’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$3.88M Buy
52,150
+1,153
+2% +$96.7K 1.39% 16
2022
Q4 		$4.75M Buy
50,997
+300
+0.6% +$28.9K 1.77% 10
2022
Q3 		$4.83M Buy
50,697
+410
+0.8% +$40.6K 1.99% 10
2022
Q2 		$4.66M Buy
50,287
+655
+1% +$63.9K 1.81% 11
2022
Q1 		$5.02M Hold
49,632
– – 1.75% 12
2021
Q4 		$5.12M Buy
49,632
+200
+0.4% +$18.5K 1.73% 11
2021
Q3 		$4.2M Buy
49,432
+1,750
+4% +$147K 1.53% 15
2021
Q2 		$3.98M Buy
47,682
+390
+0.8% +$31.9K 1.47% 15
2021
Q1 		$3.56M Buy
47,292
+5,070
+12% +$369K 1.4% 19
2020
Q4 		$2.88M Buy
42,222
+2,225
+6% +$145K 1.24% 25
2020
Q3 		$2.34M Buy
39,997
+2,205
+6% +$137K 1.14% 27
2020
Q2 		$2.46M Sell
37,792
-3,750
-9% -$236K 1.28% 21
2020
Q1 		$2.46M Buy
41,542
+1,395
+3% +$93.1K 1.44% 17
2019
Q4 		$2.98M Buy
40,147
+2,130
+6% +$150K 1.4% 19
2019
Q3 		$2.4M Buy
38,017
+850
+2% +$50.4K 1.22% 23
2019
Q2 		$2.02M Buy
37,167
+4,013
+12% +$216K 1.05% 33
2019
Q1 		$1.79M Buy
33,154
+7,776
+31% +$480K 0.97% 37
2018
Q4 		$1.66M Buy
25,378
+2,080
+9% +$155K 1.04% 33
2018
Q3 		$1.83M Buy
23,298
+1,633
+8% +$117K 1.06% 32
2018
Q2 		$1.39M Sell
21,665
-740
-3% -$48.8K 0.86% 46
2018
Q1 		$1.39M Buy
22,405
+640
+3% +$45.9K 0.86% 46
2017
Q4 		$1.58M Buy
21,765
+140
+0.6% +$10.2K 0.97% 38
2017
Q3 		$1.76M Sell
21,625
-600
-3% -$47.5K 1.13% 30
2017
Q2 		$1.79M Sell
22,225
-200
-0.9% -$15.8K 1.21% 27
2017
Q1 		$1.76M Buy
22,425
+341
+2% +$27.2K 1.26% 24
2016
Q4 		$1.74M Buy
+22,084
New +$1.79M 1.34% 20

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

LeJeune Puetz Investment Counsel's CVS Position: Q1 2023 in Review

LeJeune Puetz Investment Counsel increased its CVS Health (CVS) stake by 2.3% in Q1 2023, buying an estimated $96.7K and bringing the position to 52,150 shares worth $3.88M. The position accounts for 1.39% of the portfolio, ranked #16.

LeJeune Puetz Investment Counsel first reported a position in CVS in Q4 2016 and has held it in 26 quarters since. The position peaked at $5.12M in Q4 2021. 2,268 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • LeJeune Puetz Investment Counsel held 52,150 shares of CVS Health worth $3.88M as of Q1 2023.
  • LeJeune Puetz Investment Counsel bought 1,153 CVS Health shares in Q1 2023, an estimated $96.7K.
  • CVS Health made up 1.39% of LeJeune Puetz Investment Counsel's portfolio in Q1 2023, its #16 holding.
  • LeJeune Puetz Investment Counsel first reported a position in CVS Health in Q4 2016 and has held it in 26 quarters since.
  • LeJeune Puetz Investment Counsel's CVS Health position peaked at $5.12M in Q4 2021.
  • 2,268 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on LeJeune Puetz Investment Counsel's 13F filing for Q1 2023, filed 3 May 2023.